The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study
Authors:
Open Access
- 22 February 2024
- journal article
- research article
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 21 (1) , 1-10
Abstract
Background: Elevated fasting plasma glucose (FPG) and 2-hour post-challenge glucose (2hPG) levels are known to be independent risk factors for cardiovascular disease (CVD). However, there is limited data on the association of the difference between these measures and the risk of CVD. This study aims to investigate this association in normoglycemic Iranian adults, particularly in those with low-normal FPG levels. Methods: This prospective cohort study included 4,594 30-65-year-old participants from the Tehran Lipid and Glucose Study. Using multivariable Cox proportional hazards regression models adjusting for age, sex, body mass index, hypertension, hypercholesterolemia, smoking, education level and FPG, hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated for the association between 2hPG-FPG, both as continuous and categorical variables, and the CVD risk. Analyses of receiver operating characteristic curves were undertaken to determine the optimal 2hPG-FPG cut-off value. Results: During a median of 17.9 years of follow-up, 459 CVD events occurred. A one-unit increase in 2hPG-FPG was significantly associated with an elevated risk of cardiovascular disease in both normoglycemic (HR 1.10, 95% CI (1.01–1.19)) and low-normal FPG individuals (HR 1.16, 95% CI (1.04–1.30)); this association resisted adjustment for Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) among normoglycemic individuals. However, those with 2hPG levels greater than FPG levels had a non-significant increased risk of incident CVD compared to those with 2hPG levels of less than or equal to FPG, with corresponding HR values of 1.18 (95% CI: 0.95–1.46) in normoglycemic and 1.32 (95% CI: 0.98–1.79) in low-normal FPG, respectively. For incident CVD, the optimal cut-off value for the 2hPG-FPG was found to be 1.06 mmol/L, which was applicable for both normoglycemic and low FPG populations; using this criterion, the corresponding risks for incident CVD were 1.36 (95% CI: 1.12–1.64) and 1.57 (95% CI: 1.22–2.03), respectively. Conclusions: The difference between 2hPG and FPG levels within the normoglycemic range is related to an increased risk of CVD, an issue that was independent of HOMA-IR. A cut-off point for 2hPG-FPG > 1.06 mmol/L may stratify persons at higher risk. These findings were particularly notable in those with low-normal FPG.Keywords
This publication has 33 references indexed in Scilit:
- Inflammation, Aging, and Cardiovascular DiseaseJACC, 2022
- Association of the extent of return to fasting state 2-hours after a glucose challenge with incident prediabetes and type 2 diabetes: The CARDIA studyDiabetes Research and Clinical Practice, 2021
- Correction to: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk RecognitionCurrent Diabetes Reports, 2019
- The Global Burden of Cardiovascular Diseases and Risk FactorsJACC, 2019
- Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective studyAtherosclerosis, 2017
- Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose studyActa Diabetologica, 2011
- Coronary disease risk and fasting glucose levels in a non-diabetic populationDiabetes Research and Clinical Practice, 2011
- Differences in cardiovascular risk profile based on relationship between post‐load plasma glucose and fasting plasma levelsDiabetes/Metabolism Research and Reviews, 2009
- Glucose Tolerance and Cardiovascular MortalityArchives of internal medicine (1960), 2001
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985